Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy.

Jia H, Zack MM, Thompson WW.

Value Health. 2013 Jan-Feb;16(1):140-7. doi: 10.1016/j.jval.2012.08.2208. Epub 2012 Nov 30.

2.

Impact of depression on quality-adjusted life expectancy (QALE) directly as well as indirectly through suicide.

Jia H, Zack MM, Thompson WW, Crosby AE, Gottesman II.

Soc Psychiatry Psychiatr Epidemiol. 2015 Jun;50(6):939-49. doi: 10.1007/s00127-015-1019-0. Epub 2015 Feb 7.

3.

Quality-adjusted life expectancy (QALE) loss due to smoking in the United States.

Jia H, Zack MM, Thompson WW, Dube SR.

Qual Life Res. 2013 Feb;22(1):27-35. doi: 10.1007/s11136-012-0118-6. Epub 2012 Feb 18.

4.

State Quality-Adjusted Life Expectancy for U.S. adults from 1993 to 2008.

Jia H, Zack MM, Thompson WW.

Qual Life Res. 2011 Aug;20(6):853-63. doi: 10.1007/s11136-010-9826-y. Epub 2011 Jan 6.

PMID:
21210226
5.

Comparing quality-adjusted life expectancy at different levels of physical activity.

Jia H, Lubetkin EI.

J Phys Act Health. 2014 Feb;11(2):278-84. doi: 10.1123/jpah.2011-0368. Epub 2013 Jan 30.

PMID:
23364410
6.

Population-Based Estimates of Decreases in Quality-Adjusted Life Expectancy Associated with Unhealthy Body Mass Index.

Jia H, Zack MM, Thompson WW.

Public Health Rep. 2016 Jan-Feb;131(1):177-84.

PMID:
26843684
7.

Using a survey to estimate health expectancy and quality-adjusted life expectancy to assess inequalities in health and quality of life.

Collins B.

Value Health. 2013 Jun;16(4):599-603. doi: 10.1016/j.jval.2013.01.004. Epub 2013 Mar 26.

8.

Health-related quality of life, quality-adjusted life years, and quality-adjusted life expectancy in new york city from 1995 to 2006.

Lubetkin EI, Jia H.

J Urban Health. 2009 Jul;86(4):551-61. doi: 10.1007/s11524-009-9344-9. Epub 2009 Mar 13.

9.

Impact of delaying blood pressure control in patients with Type 2 diabetes: results of a decision analysis.

Laiteerapong N, John PM, Meltzer DO, Huang ES.

J Gen Intern Med. 2012 Jun;27(6):640-6. doi: 10.1007/s11606-011-1951-y. Epub 2012 Jan 4.

10.

The Social Distribution of Health: Estimating Quality-Adjusted Life Expectancy in England.

Love-Koh J, Asaria M, Cookson R, Griffin S.

Value Health. 2015 Jul;18(5):655-62. doi: 10.1016/j.jval.2015.03.1784. Epub 2015 Apr 18.

PMID:
26297094
11.

Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage: a 13-year follow-up.

Lee HY, Hwang JS, Jeng JS, Wang JD.

Stroke. 2010 Apr;41(4):739-44. doi: 10.1161/STROKEAHA.109.573543. Epub 2010 Feb 11.

12.

Prevalence of diabetes and cardiovascular comorbidity in the Canadian Community Health Survey 2002-2003.

Mo F, Pogany LM, Li FC, Morrison H.

ScientificWorldJournal. 2006 Jan 24;6:96-105.

13.

The effect of revised populations on mortality statistics for the United States, 2000.

Anderson RN, Arias E.

Natl Vital Stat Rep. 2003 Jun 5;51(9):1-24.

14.

Using the years-of-healthy-life measure to calculate QALYs.

Muennig PA, Gold MR.

Am J Prev Med. 2001 Jan;20(1):35-9.

PMID:
11137772
15.

Comparison of expected health impacts for major cancers: integration of incidence rate and loss of quality-adjusted life expectancy.

Hung MC, Lai WW, Chen HH, Su WC, Wang JD.

Cancer Epidemiol. 2015 Feb;39(1):126-32. doi: 10.1016/j.canep.2014.12.004. Epub 2014 Dec 30.

16.

Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: adjusting quality-of-life and lead-time bias for utility of surgery.

Yang SC, Lai WW, Chang HY, Su WC, Chen HH, Wang JD.

Lung Cancer. 2014 Oct;86(1):96-101. doi: 10.1016/j.lungcan.2014.08.006. Epub 2014 Aug 18.

17.

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.

Murray CJ, Atkinson C, Bhalla K, Birbeck G, Burstein R, Chou D, Dellavalle R, Danaei G, Ezzati M, Fahimi A, Flaxman D, Foreman, Gabriel S, Gakidou E, Kassebaum N, Khatibzadeh S, Lim S, Lipshultz SE, London S, Lopez, MacIntyre MF, Mokdad AH, Moran A, Moran AE, Mozaffarian D, Murphy T, Naghavi M, Pope C, Roberts T, Salomon J, Schwebel DC, Shahraz S, Sleet DA, Murray, Abraham J, Ali MK, Atkinson C, Bartels DH, Bhalla K, Birbeck G, Burstein R, Chen H, Criqui MH, Dahodwala, Jarlais, Ding EL, Dorsey ER, Ebel BE, Ezzati M, Fahami, Flaxman S, Flaxman AD, Gonzalez-Medina D, Grant B, Hagan H, Hoffman H, Kassebaum N, Khatibzadeh S, Leasher JL, Lin J, Lipshultz SE, Lozano R, Lu Y, Mallinger L, McDermott MM, Micha R, Miller TR, Mokdad AA, Mokdad AH, Mozaffarian D, Naghavi M, Narayan KM, Omer SB, Pelizzari PM, Phillips D, Ranganathan D, Rivara FP, Roberts T, Sampson U, Sanman E, Sapkota A, Schwebel DC, Sharaz S, Shivakoti R, Singh GM, Singh D, Tavakkoli M, Towbin JA, Wilkinson JD, Zabetian A, Murray, Abraham J, Ali MK, Alvardo M, Atkinson C, Baddour LM, Benjamin EJ, Bhalla K, Birbeck G, Bolliger I, Burstein R, Carnahan E, Chou D, Chugh SS, Cohen A, Colson KE, Cooper LT, Couser W, Criqui MH, Dabhadkar KC, Dellavalle RP, Jarlais, Dicker D, Dorsey ER, Duber H, Ebel BE, Engell RE, Ezzati M, Felson DT, Finucane MM, Flaxman S, Flaxman AD, Fleming T, Foreman, Forouzanfar MH, Freedman G, Freeman MK, Gakidou E, Gillum RF, Gonzalez-Medina D, Gosselin R, Gutierrez HR, Hagan H, Havmoeller R, Hoffman H, Jacobsen KH, James SL, Jasrasaria R, Jayarman S, Johns N, Kassebaum N, Khatibzadeh S, Lan Q, Leasher JL, Lim S, Lipshultz SE, London S, Lopez, Lozano R, Lu Y, Mallinger L, Meltzer M, Mensah GA, Michaud C, Miller TR, Mock C, Moffitt TE, Mokdad AA, Mokdad AH, Moran A, Naghavi M, Narayan KM, Nelson RG, Olives C, Omer SB, Ortblad K, Ostro B, Pelizzari PM, Phillips D, Raju M, Razavi H, Ritz B, Roberts T, Sacco RL, Salomon J, Sampson U, Schwebel DC, Shahraz S, Shibuya K, Silberberg D, Singh JA, Steenland K, Taylor JA, Thurston GD, Vavilala MS, Vos T, Wagner GR, Weinstock MA, Weisskopf MG, Wulf S, Murray; U.S. Burden of Disease Collaborators.

JAMA. 2013 Aug 14;310(6):591-608. doi: 10.1001/jama.2013.13805.

PMID:
23842577
18.

The global impact of noncommunicable diseases: estimates and projections.

Manton KG.

World Health Stat Q. 1988;41(3-4):255-66.

PMID:
3232413
19.

Multiple chronic conditions: diabetes associated with comorbidity and shared risk factors using CDC WEAT and SAS analytic tools.

Fisher MA, Ma ZQ.

J Prim Care Community Health. 2014 Apr 1;5(2):112-21. doi: 10.1177/2150131913503347. Epub 2013 Sep 10.

PMID:
24327591
20.

Estimating quality-adjusted life-year loss due to noncommunicable diseases in Korean adults through to the year 2040.

Ock M, Han JW, Lee JY, Kim SH, Jo MW.

Value Health. 2015 Jan;18(1):61-6. doi: 10.1016/j.jval.2014.09.008.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk